TAVR for aortic valve regurgitation: Ready for a randomized trial? Journal Articles

abstract

• Key Points Transcatheter aortic valve replacement has been used successfully to treat native aortic valve regurgitation. Current observational evidence shows promising results in terms of procedural success while outcome data are difficult to interpret given the observational nature of the evidence. We are ready for a randomized trial, which will be very challenging to run.

authors

• Belardi, Jorge
• Lamelas, Pablo

status

• published 

publication date

• February 2019

has subject area

• 1102 Cardiorespiratory Medicine and Haematology (FoR)
• Aortic Valve (MeSH)
• Aortic Valve Insufficiency (MeSH)
• Aortic Valve Stenosis (MeSH)
• Cardiovascular System & Hematology (Science Metrix)
• Heart Valve Prosthesis (MeSH)
• Heart Valve Prosthesis Implantation (MeSH)
• Humans (MeSH)
• Transcatheter Aortic Valve Replacement (MeSH)
• Treatment Outcome (MeSH)

published in

• Catheterization and Cardiovascular Interventions  Journal

keywords

• Aortic Valve
• Aortic Valve Insufficiency
• Aortic Valve Stenosis
• Heart Valve Prosthesis
• Heart Valve Prosthesis Implantation
• Humans
• Transcatheter Aortic Valve Replacement
• Treatment Outcome

Digital Object Identifier (DOI)

• 10.1002/ccd.28079

PubMed ID

• 30719856

start page

• 354

end page

• 355

volume

• 93

issue

• 2